BMY vs. SCHD
Compare and contrast key facts about Bristol-Myers Squibb Company (BMY) and Schwab US Dividend Equity ETF (SCHD).
SCHD is a passively managed fund by Charles Schwab that tracks the performance of the Dow Jones U.S. Dividend 100 Index. It was launched on Oct 20, 2011.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BMY or SCHD.
Correlation
The correlation between BMY and SCHD is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
BMY vs. SCHD - Performance Comparison
Key characteristics
BMY:
0.58
SCHD:
0.24
BMY:
1.11
SCHD:
0.44
BMY:
1.13
SCHD:
1.06
BMY:
0.37
SCHD:
0.24
BMY:
2.48
SCHD:
0.83
BMY:
7.03%
SCHD:
4.59%
BMY:
29.98%
SCHD:
15.97%
BMY:
-70.62%
SCHD:
-33.37%
BMY:
-31.20%
SCHD:
-10.95%
Returns By Period
In the year-to-date period, BMY achieves a -9.29% return, which is significantly lower than SCHD's -4.64% return. Over the past 10 years, BMY has underperformed SCHD with an annualized return of 0.68%, while SCHD has yielded a comparatively higher 10.39% annualized return.
BMY
-9.29%
-16.80%
-2.57%
19.86%
0.01%
0.68%
SCHD
-4.64%
-7.65%
-6.69%
4.48%
13.39%
10.39%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BMY vs. SCHD — Risk-Adjusted Performance Rank
BMY
SCHD
BMY vs. SCHD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bristol-Myers Squibb Company (BMY) and Schwab US Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BMY vs. SCHD - Dividend Comparison
BMY's dividend yield for the trailing twelve months is around 4.86%, more than SCHD's 4.03% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.86% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
SCHD Schwab US Dividend Equity ETF | 4.03% | 3.64% | 3.49% | 3.39% | 2.78% | 3.16% | 2.98% | 3.06% | 2.63% | 2.89% | 2.97% | 2.63% |
Drawdowns
BMY vs. SCHD - Drawdown Comparison
The maximum BMY drawdown since its inception was -70.62%, which is greater than SCHD's maximum drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for BMY and SCHD. For additional features, visit the drawdowns tool.
Volatility
BMY vs. SCHD - Volatility Comparison
The current volatility for Bristol-Myers Squibb Company (BMY) is 10.15%, while Schwab US Dividend Equity ETF (SCHD) has a volatility of 11.11%. This indicates that BMY experiences smaller price fluctuations and is considered to be less risky than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.